Evidence map›Paper›PMID 25215302›Full record

ArticleJournal of diabetes research2014

Vanadyl sulfate treatment stimulates proliferation and regeneration of beta cells in pancreatic islets.

Samira Missaoui, Khémais Ben Rhouma, Mohamed-Tahar Yacoubi, Mohsen Sakly, Olfa Tebourbi

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. A Dioxidovanadium ComplexEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.International journal of molecular sciences · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Samira MissaouiLaboratory of Integrated Physiology, Faculty of Sciences of Bizerte, University of Carthage, 7021 Jarzouna, Tunisia.
Khémais Ben RhoumaLaboratory of Integrated Physiology, Faculty of Sciences of Bizerte, University of Carthage, 7021 Jarzouna, Tunisia.
Mohamed-Tahar YacoubiDepartment of Pathological Anatomy, Farhat Hached University Hospital, 4000 Sousse, Tunisia.
Mohsen SaklyLaboratory of Integrated Physiology, Faculty of Sciences of Bizerte, University of Carthage, 7021 Jarzouna, Tunisia.
Olfa TebourbiLaboratory of Integrated Physiology, Faculty of Sciences of Bizerte, University of Carthage, 7021 Jarzouna, Tunisia.
University of Carthage · TNHôpital Farhat Hached · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the effects of vanadium sulfate (VOSO4) treatment at 5 and 10 mg/kg for 30 days on endocrine pancreas activity and histology in nondiabetic and STZ-induced diabetic rats. In diabetic group, blood glucose levels significantly increased while insulinemia level markedly decreased. At the end of treatment, VOSO4 at a dose of 10 mg/Kg normalized blood glucose level in diabetic group, restored insulinemia, and significantly improved insulin sensitivity. VOSO4 also increased in a dose-dependent manner the number of insulin immunopositive beta cells in pancreatic islets of nondiabetic rats. Furthermore, in the STZ-diabetic group, the decrease in the number of insulin immunopositive beta cells was corrected to reach the control level mainly with the higher dose of vanadium. Therefore, VOSO4 treatment normalized plasma glucose and insulin levels and improved insulin sensitivity in STZ-experimental diabetes and induced beta cells proliferation and/or regeneration in normal or diabetic rats.

Indexed as

AnimalsBiomarkersBlood GlucoseCell ProliferationDiabetes Mellitus, ExperimentalHypoglycemic AgentsInsulinInsulin-Secreting CellsMaleRats, WistarRegenerationStreptozocinTime FactorsVanadium CompoundsBiomarkersBlood GlucoseHypoglycemic AgentsInsulinStreptozocinVanadium Compoundsvanadyl sulfate

Identifiers

PMID25215302
PMCPMC4156977
OpenAlexW2108328909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.